Neoleukin Therapeutics Price on July 20, 2023

NLTXDelisted Stock  USD 0.69  0.01  1.43%   
If you're considering investing in Neoleukin Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neoleukin Therapeutics stands at 0.69, as last reported on the 4th of December, with the highest price reaching 0.71 and the lowest price hitting 0.67 during the day. We have found twenty-four technical indicators for Neoleukin Therapeutics, which you can use to evaluate the volatility of the firm. Please verify Neoleukin Therapeutics' Risk Adjusted Performance of (0.03), mean deviation of 2.25, and Standard Deviation of 3.7 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Neoleukin Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
NLTX
Based on monthly moving average Neoleukin Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neoleukin Therapeutics by adding Neoleukin Therapeutics to a well-diversified portfolio.

Neoleukin Therapeutics Valuation on July 20, 2023

It is possible to determine the worth of Neoleukin Therapeutics on a given historical date. On July 20, 2023 Neoleukin was worth 0.67 at the beginning of the trading date compared to the closed value of 0.67. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Neoleukin Therapeutics stock. Still, in general, we apply an absolute valuation method to find Neoleukin Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neoleukin Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Neoleukin Therapeutics' related companies.
 Open High Low Close Volume
  0.73    0.75    0.65    0.66    1,247,610  
07/20/2023
  0.67    0.69    0.65    0.67    1,185,876  
  0.72    0.74    0.69    0.70    997,276  
Backtest Neoleukin Therapeutics  |  Neoleukin Therapeutics History  |  Neoleukin Therapeutics Valuation   PreviousNext  
Open Value
0.67
0.67
Closing Value
0.67
Upside

Neoleukin Therapeutics Trading Date Momentum on July 20, 2023

On July 21 2023 Neoleukin Therapeutics was traded for  0.70  at the closing time. The top price for the day was 0.74  and the lowest listed price was  0.69 . The trading volume for the day was 997.3 K. The trading history from July 21, 2023 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 4.48% . The trading delta at closing time against the current closing price is 4.48% .

Neoleukin Therapeutics Fundamentals Correlations and Trends

By evaluating Neoleukin Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Neoleukin Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Neoleukin financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Neoleukin Therapeutics Stock history

Neoleukin Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neoleukin is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neoleukin Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neoleukin Therapeutics stock prices may prove useful in developing a viable investing in Neoleukin Therapeutics
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington. Neoleukin Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 79 people.

Neoleukin Therapeutics Stock Technical Analysis

Neoleukin Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Neoleukin Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Neoleukin Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Neoleukin Therapeutics Period Price Range

Low
December 4, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Neoleukin Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Neoleukin Therapeutics December 4, 2024 Market Strength

Market strength indicators help investors to evaluate how Neoleukin Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neoleukin Therapeutics shares will generate the highest return on investment. By undertsting and applying Neoleukin Therapeutics stock market strength indicators, traders can identify Neoleukin Therapeutics entry and exit signals to maximize returns

Neoleukin Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Neoleukin Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Neoleukin Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neoleukin to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Consideration for investing in Neoleukin Stock

If you are still planning to invest in Neoleukin Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neoleukin Therapeutics' history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Transaction History
View history of all your transactions and understand their impact on performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments